Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector ...
Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback